Congruence Therapeutics
Computational platform for small molecule discovery targeting protein misfolding diseases
1
Funding Rounds
$50.0m
Money raised
Funding series
Funding Series Analysis
The company Congruence Therapeutics has raised a total of $50m in funding over 1 rounds.
Key Insights:
- Congruence Therapeutics Series A round, February 8, 2022: $50m
Congruence Therapeutics Series A round, February 8, 2022
$50m
Industries
Congruence Therapeutics is active in the following industries: